...
首页> 外文期刊>Dermatologic Therapy >THERAPEUTIC HOTLINE: Primary cutaneous CD4 + small/medium-sized pleomorphic T cell lymphoma coexisting with myelodysplastic syndrome transforming into chronic myelomonocytic leukemia successfully treated with cyclophosphamide
【24h】

THERAPEUTIC HOTLINE: Primary cutaneous CD4 + small/medium-sized pleomorphic T cell lymphoma coexisting with myelodysplastic syndrome transforming into chronic myelomonocytic leukemia successfully treated with cyclophosphamide

机译:治疗热线:原发性皮肤CD4 +中小型多形性T细胞淋巴瘤与骨髓增生异常综合征并存,成功转化为慢性粒单核细胞白血病,并成功用环磷酰胺治疗

获取原文
获取原文并翻译 | 示例
           

摘要

Cutaneous T cell lymphomas other than mycosis fungoides, Sezary syndrome, and primary cutaneous CD30+ lymphoproliferations constitute less than 10% of all cutaneous T cell lymphomas. Primary cutaneous small/medium CD4+ T cell lymphoma is a member of this third group of cutaneous lymphomas, separated out as provisional entity in the World Health Organization classification – European Organization for Research and Treatment of Cancer (WHO-EORTC) classification. It still awaits development of more precise diagnostic criteria and optimal therapy.
机译:除真菌病,Sezary综合征和原发性皮肤CD30 +淋巴组织增生外,皮肤T细胞淋巴瘤占所有皮肤T细胞淋巴瘤的比例不到10%。原发性皮肤小/中CD4 + T细胞淋巴瘤是这第三类皮肤淋巴瘤的成员,在世界卫生组织分类-欧洲癌症研究和治疗组织(WHO-EORTC)分类中作为临时实体被分离出来。它仍在等待更精确的诊断标准和最佳疗法的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号